Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

434 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Teratogenesis and immunosuppressive treatment.
Danesi R, Del Tacca M. Danesi R, et al. Transplant Proc. 2004 Apr;36(3):705-7. doi: 10.1016/j.transproceed.2004.03.017. Transplant Proc. 2004. PMID: 15110638
Suramin as an anticomplementary agent in xenotransplantation.
Carobbi A, Di Stefano R, Danesi R, Carmellini M, Ferrari M, Galatioto C, Ermini M, Mosca F. Carobbi A, et al. Transplant Proc. 1992 Apr;24(2):700. Transplant Proc. 1992. PMID: 1566488 No abstract available.
Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529.
Agen C, Bernardini N, Danesi R, Della Torre P, Costa M, Del Tacca M. Agen C, et al. Cancer Chemother Pharmacol. 1992;30(2):95-9. doi: 10.1007/BF00686399. Cancer Chemother Pharmacol. 1992. PMID: 1600601
Pharmacokinetic optimisation of the treatment of cancer with high dose zidovudine.
Danesi R, Falcone A, Conte PF, Del Tacca M. Danesi R, et al. Clin Pharmacokinet. 1998 Feb;34(2):173-80. doi: 10.2165/00003088-199834020-00005. Clin Pharmacokinet. 1998. PMID: 9515187 Review.
Pharmacogenetic determinants of anti-cancer drug activity and toxicity.
Danesi R, De Braud F, Fogli S, Di Paolo A, Del Tacca M. Danesi R, et al. Trends Pharmacol Sci. 2001 Aug;22(8):420-6. doi: 10.1016/s0165-6147(00)01742-9. Trends Pharmacol Sci. 2001. PMID: 11479005 Review.
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs.
Danesi R, Fogli S, Gennari A, Conte P, Del Tacca M. Danesi R, et al. Clin Pharmacokinet. 2002;41(6):431-44. doi: 10.2165/00003088-200241060-00004. Clin Pharmacokinet. 2002. PMID: 12074691 Review.
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients.
Di Paolo A, Ibrahim T, Danesi R, Maltoni M, Vannozzi F, Flamini E, Zoli W, Amadori D, Del Tacca M. Di Paolo A, et al. Ther Drug Monit. 2002 Oct;24(5):588-93. doi: 10.1097/00007691-200210000-00002. Ther Drug Monit. 2002. PMID: 12352929
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
Bengala C, Danesi R, Guarneri V, Pazzagli I, Donati S, Favre C, Fogli S, Biadi O, Innocenti F, Del Tacca M, Mariani M, Conte PF. Bengala C, et al. Bone Marrow Transplant. 2003 Feb;31(4):275-80. doi: 10.1038/sj.bmt.1703827. Bone Marrow Transplant. 2003. PMID: 12621462
434 results
Jump to page
Feedback